Get started
Author

Narendra Nath Khanna

Observed names: Narendra N. Khanna, Narendra Khanna, Narendra N Khanna, Narendra N. Khanna
ORCID: 0000-0003-2957-3825
Observed ORCID: 0000-0003-2957-3825
OpenAlex ID: A5101767286
Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review
2024 · Manasvi Singh, Ashish Kumar, et al. · EClinicalMedicine · 199
PDF
Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review
2023 · Narendra N Khanna, Manasvi Singh, et al. · Journal of Korean Medical Science · 37
PDF
Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India
2020 · Raman Puri, Vimal Mehta, et al. · Journal of clinical lipidology · 30
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement
2024 · Hirday Kumar Chopra, Gurpreet S Wander, et al. · Journal of the Association of Physicians of India · 4
StockAI 3.0: Ensemble fusion paradigms using novel gating mechanism in long short-term memory architectures for forecasting sentiment-based stock trends
2025 · Yuvraj Sharma, Siddharth Gupta, et al. · Soft Computing · 3
Comparative study of transformer-based models for cardiovascular disease risk stratification with tabular biomarker data
2026 · Yuvraj Sharma, Ekta Tiwari, et al. · Artificial Intelligence in Health · 1
PDF
A systematic review on cardiovascular risk stratification in the artificial intelligence paradigm using radiogenomics
2026 · Manasvi Singh, Narendra Khanna, et al. · Exploration of Cardiology
PDF
Identification of high-risk genes and classification of acute myocardial infarction patients utilizing deep learning in a restricted cohort
2026 · Krish Chaudhary, Narendra N. Khanna, et al. · Computers in Biology and Medicine
Works count: 10
Citation count: 274
H-index: 4
I10-index: 3
Year
Topic
Type